证券日报网讯华特气体11月25日在互动平台回答投资者提问时表示，2025年10月31日公司股东人数为 13399户。 （文章来源：证券日报） ...

分组1 - Weili Medical plans to distribute a cash dividend of 2 yuan per 10 shares to all shareholders, based on an undistributed profit of 704 million yuan as of September 30, 2025 [1] - Tongding Interconnect's shareholder plans to reduce their stake by up to 0.49%, equating to a maximum of 605,800 shares [1] - Caitong Securities has received approval from the China Securities Regulatory Commission to issue short-term corporate bonds with a total face value of up to 5 billion yuan [1] 分组2 - Youfu Food intends to use 70 million yuan of its own funds to invest in wealth management products with expected annual returns of up to 4.2% [3] - Keres received an administrative regulatory decision from the Guangdong Securities Regulatory Bureau for violations related to accounts receivable aging calculations and related party transactions [5] - Ouma Software's controlling shareholder has completed the transfer of state-owned equity, changing the controlling shareholder to Shandong Guotou [7] 分组3 - ST Huapeng's wholly-owned subsidiary has completed a major overhaul project and is now in production [8] - Beiqi Blue Valley has received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [8] - Weijie Chuangxin received a government subsidy of 5 million yuan, accounting for 21.07% of its projected net profit for 2024 [9] 分组4 - China Resources Double Crane's subsidiary has received a drug registration certificate for a hypertension treatment drug [11] - Huafeng shares are continuing to suspend trading due to a planned change in control [13] - Kaifa Electric's shareholder plans to transfer 36.6869 million shares, representing 11.63% of the total share capital [14] 分组5 - Heng Rui Medicine has received approval for two clinical trials for innovative anti-tumor drugs [15] - Kosen Technology plans to invest 30 million USD to establish a new production base in Malaysia [17] - Sanxing Medical's subsidiary is expected to win a procurement project from the State Grid worth approximately 107 million yuan [18] 分组6 - Sitai Li's subsidiary has received a drug registration certificate for a contrast agent used in MRI [21] - Daren Tang's subsidiary has received a drug registration certificate for a pain relief gel [22] - Saike Xide has received approval for three medical device products, expanding its product range in the in vitro diagnostic field [23] 分组7 - Hasa Lian has elected a new chairman and vice chairman for its board of directors [24] - Two-sided Needle's subsidiary plans to invest 68.8522 million yuan in a production base expansion project [25] - Sunshine Nuohe plans to transfer 70% of its controlling subsidiary's equity for 2 million yuan [26] 分组8 - Hengbang shares received an administrative regulatory decision from the Shandong Securities Regulatory Bureau for failing to complete the election of independent directors [27] - Huali shares plan to sign a related transaction contract worth approximately 59.2847 million yuan [28] - Shangwei shares plan to invest 520.4 million yuan to gain a controlling stake in Sichuan Zhongfu Taihua [30] 分组9 - Zejing Pharmaceutical's ZG006 has been included in the list of breakthrough therapeutic varieties for treating advanced neuroendocrine cancer [32] - Yaopi Glass's shareholder plans to reduce their stake by up to 2.26%, equating to a maximum of 21.1469 million shares [34] - Huate Gas has initiated a major lawsuit involving a claim of 180 million yuan [36] 分组10 - Zhongchumei's controlling shareholder plans to increase their stake by between 42 million and 80 million yuan [37] - Huitong shares' shareholder plans to reduce their stake by up to 1% [38] - Miaowei Exhibition plans to apply for an initial public offering of H shares on the Hong Kong Stock Exchange [40] 分组11 - Tianqi Lithium's subsidiary has appealed to the Chilean Supreme Court regarding a partnership agreement with SQM and Codelco [42] - Naxin Micro plans to repurchase shares worth between 200 million and 400 million yuan [44] - Pingao shares have reported significant uncertainty regarding future business development and profitability [46] 分组12 - Shunyu shares have been pre-selected for a project worth 1.023 billion yuan [48] - Zhongyuan Neipei plans to acquire a 2.5% share in an aerospace industry fund for 50 million yuan [50] - Huifa Food's shareholder plans to reduce their stake by up to 3%, equating to a maximum of 727.14 million shares [53] 分组13 - Junshi Biosciences' subcutaneous PD-1 new formulation has reached its primary endpoint in a Phase III clinical trial [54] - Industrial Fulian clarified that it has not lowered its fourth-quarter profit target amid market rumors [55] - Longpan Technology's subsidiary has signed a major supply agreement for lithium iron phosphate materials, significantly increasing the supply volume [56]

分析人士指出，大额违约金主张一方面体现出公司维护自身权益的态度，但诉讼周期、举证难度及执行效果等因素，都可能对最终回款节奏及财务报表反映 形成差异。 华特气体在公告中重申，公司目前生产经营活动正常开展，本次诉讼不会对公司日常运营产生实质性影响。公司将持续强化合同管理和合规风控，并提示广 大投资者理性判断诉讼事项的不确定性风险，注意二级市场交易风险。 （校对/秋贤） 公告显示，华特气体请求法院判令赖明贵等被告支付违约金人民币1.8亿元，并承担案件受理费、保全费等全部诉讼费用。公司强调，本次纠纷源于股权转 让相关协议履行过程中的争议，目前尚处于诉前财产保全和正式立案阶段，案件尚未开庭审理，最终判决结果及执行情况仍存在不确定性。 华特气体表示，公司将积极通过法律途径维护自身合法权益，并根据案件进展情况严格依照监管要求履行持续信息披露义务。公司提醒投资者，目前难以对 案件可能产生的责任承担和经济后果作出准确判断，相关事项对公司本期利润及期后利润的影响尚无法预计。 （文/罗叶馨梅）11月24日，华特气体（688268.SH）发布公告称，公司就与赖明贵、四川中氟能新材料科技有限公司、罗君之间的股权转让纠纷，已向广东 省佛 ...

Core Viewpoint - Huate Gas has filed a significant lawsuit regarding a share transfer dispute, with the amount involved reaching 180 million yuan, and the case has been accepted by the court but has not yet been heard [1] Group 1: Lawsuit Details - The plaintiff in the lawsuit is Huate Gas, while the defendants include Lai Minggui, Sichuan Zhongfu Energy New Materials Technology Co., Ltd., and Luo Jun [1] - The lawsuit stems from a series of cooperation agreements signed in 2022, including a key agreement that granted Huate Gas exclusive rights to certain gas interests and stipulated a penalty of 180 million yuan for breaches [1] - A supplementary agreement was signed in October 2022, which established joint liability for Luo Jun and Zhongfu Energy regarding the performance of the cooperation agreement [1] Group 2: Allegations of Breach - Huate Gas discovered multiple breaches by Lai Minggui, including participation in a third-party bidding process for NF3 and selling NF3 to other parties, violating the exclusivity agreement [2] - Additional breaches included delays in project commencement, failure to provide accurate project progress updates, and unilateral requests to terminate the cooperation agreement, which Huate Gas deemed as substantial breaches [2] - Huate Gas has previously filed a lawsuit against Lai Minggui for some of these breaches, and this current lawsuit addresses further violations, seeking 180 million yuan in penalties and joint liability from the other defendants [2] Group 3: Legal Proceedings and Financial Impact - Huate Gas has applied for property preservation measures to protect its legal rights and prevent the concealment or transfer of assets during the litigation process [2] - The company has received confirmation from the court regarding the completion of property preservation measures and has disclosed the lawsuit after the reason for delayed disclosure was resolved [3] - The case has not yet been heard, and the final judgment remains uncertain, making it difficult for the company to predict the impact on current or future profits [3]

华特气体公告，公司诉赖明贵、四川中氟能新材料科技有限公司、罗君股权转让纠纷一案已由广东省佛 山市中级人民法院立案受理。公司要求被告支付违约金人民币1.8亿元，并承担案件受理费、保全费等 全部诉讼费用。目前诉讼尚未开庭审理，判决结果不确定，无法预计对公司本期利润或期后利润的影 响。 ...

| | | 广东华特气体股份有限公司 关于提起重大诉讼的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 案件所处的诉讼阶段：已立案受理，尚未开庭审理 上市公司所处的当事人地位：广东华特气体股份有限公司（以下简称"公 司"）为原告 涉案的金额：人民币 1.8 亿元 是否会对上市公司损益产生负面影响：本次诉讼尚未开庭审理，最终的 判决结果尚不确定，目前无法预计对公司本期利润或期后利润的影响，最终实际 影响需以法院生效判决结果为准。公司将根据相关诉讼进展情况及时履行信息披 露义务，敬请投资者注意投资风险。 一、本次诉讼的基本情况 截止本公告披露日，该案件已立案受理，尚未开庭审理。 二、诉讼案件的基本情况 （一）诉讼当事人 原告：广东华特气体股份有限公司 被告一：赖明贵 被告二：四川中氟能新材料科技有限公司（以下简称"中氟能公司"） 被告三：罗君 2025 年 11 月 10 日，公司收到广东省佛山市中级人民法院送达的关于公司 诉赖明贵、四川中氟能新材料科技有限公司、罗君股权转让纠纷一案的《受理案 件通知书》 ...

Core Viewpoint - The investigation into the "12·4" major collapse accident of the Shenzhen-Jiangmen Railway revealed that the accident was caused by violations in construction practices and inadequate emergency response measures, leading to significant casualties and economic losses [2][3]. Group 1: Accident Details - The collapse occurred on December 4, 2024, resulting in 13 fatalities and direct economic losses of approximately 72.61 million yuan [2]. - The direct cause of the accident was identified as the failure to halt excavation when encountering a high-risk geological area, leading to a partial collapse of the tunnel face [2][3]. Group 2: Responsibility and Management Issues - The investigation found that multiple parties, including China Railway Fourth Engineering Group Co., Ltd. (中铁四局), Xiamen-Shenzhen Railway Guangdong Co., Ltd. (厦深公司), and others, failed in their management and risk control responsibilities [3][4]. - The supervising unit, Guangzhou Supervision Station, and the industry regulatory body, Guangzhou Railway Supervision Administration, were also found lacking in their oversight duties [3][4]. Group 3: Lessons Learned and Recommendations - Six major lessons were identified, including failures in risk prevention, monitoring, and emergency response systems, as well as the dangers of proceeding with construction before design changes [5]. - Six recommendations were proposed to improve safety, including enhancing risk prevention measures, strengthening construction safety protocols, and improving emergency response capabilities [5].

广东华特气体股份有限公司 2025 年第二次临时股东会会议资料 证券代码：688268 证券简称：华特气体 广东华特气体股份有限公司 2025 年第二次临时股东会会议资料 2025 年 12 月 广东华特气体股份有限公司 2025 年第二次临时股东会会议资料 广东华特气体股份有限公司 二、为保证本次会议的严肃性和正常秩序，切实维护与会股东（或股东代理 人）的合法权益，除出席会议的股东（或股东代理人）、公司董事、高级管理人 员、见证律师及董事会邀请的人员外，公司有权依法拒绝其他无关人员进入会场。 三、出席会议的股东及股东代理人须在会议召开前 15 分钟到会议现场办理 签到手续，并请按规定出示有效身份证明文件或企业营业执照/注册证书复印件 （加盖公章）、授权委托书等，经验证后领取会议资料，方可出席会议。会议开 始后，由会议主持人宣布现场出席会议的股东人数及其所持有表决权的股份总数， 在此之后进出的股东无权参与现场投票表决。 四、会议按照会议通知上所列顺序审议、表决议案。 五、股东及股东代理人参加股东会依法享有发言权、质询权、表决权等权利。 股东及股东代理人参加股东会应认真履行其法定义务，不得侵犯公司和其他股东 及 ...

Core Insights - The A-share market's photoresist concept stocks are experiencing a counter-trend rise, with notable increases in stock prices for several companies ahead of a key industry conference [1] Group 1: Stock Performance - Gao Meng New Materials saw a rise of over 13%, while Sai Microelectronics increased by over 11% [1] - Other companies such as Guofeng New Materials and Kaimete Gas reached the daily limit increase of 10%, with Huasoft Technology rising over 7% [1] - Shanghai Xinyang, Huate Gas, Jiaxian Co., Tongcheng New Materials, and Nanda Optoelectronics all experienced increases of over 4% [1] Group 2: Market Context - The "2025 Photoresist and Integrated Circuit Materials Advanced Technology and Industry Application Seminar" is scheduled to take place on November 20-21, with the theme "Photoresist Breakthrough, Material Gathering in Shaoxing" [1]

Group 1 - The core viewpoint of the news is the performance and financial details of Huate Gas, which saw a stock price increase of 5.08% to 62.00 CNY per share, with a total market capitalization of 7.459 billion CNY [1] - Huate Gas, established on February 5, 1999, and listed on December 26, 2019, specializes in the research, production, and sales of specialty gases, with revenue composition as follows: specialty gases 62.52%, industrial gases 22.01%, equipment and engineering 11.98%, and others 3.49% [1] Group 2 - In terms of fund holdings, Invesco Great Wall Fund has a significant position in Huate Gas, with its "Invesco Great Wall Pension 2055 Five-Year Holding Mixed FOF" holding 1,700 shares, representing 0.93% of the fund's net value, ranking as the eighth largest holding [2] - The fund was established on May 13, 2025, with a current scale of 11.9369 million CNY and has achieved a return of 14.88% since inception [2] - The fund manager, Jiang Hong, has been in the position for 4 years and 66 days, managing total assets of 1.491 billion CNY, with the best and worst fund returns during the tenure being 27.99% and -16.79%, respectively [2]